Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer

Science

Volumn 342, Issue 6165, 2013, Pages 1484-1490

  Lyumkis, Dmitry ^a   Julien, Jean Philippe ^a   De Val, Natalia ^a   Cupo, Albert ^b   Potter, Clinton S ^a   Klasse, Per Johan ^b   Burton, Dennis R ^a,c   Sanders, Rogier W ^b,d   Moore, John P ^b   Carragher, Bridget ^a   Wilson, Ian A ^a   Ward, Andrew B ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ENVELOPE PROTEIN; EPITOPE; GLYCAN; GLYCOPROTEIN GP 140; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIBODY; ELECTRON MICROSCOPY; GENOME; HUMAN IMMUNODEFICIENCY VIRUS; VACCINE;

ARTICLE; BINDING SITE; CELL STRAIN HEK293; COMPLEX FORMATION; CRYOELECTRON MICROSCOPY; DRUG DESIGN; GLYCOSYLATION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BINDING; SOLUBILITY; STRUCTURE ANALYSIS; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS GENOME;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84890859441     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1245627     Document Type: Article

References (54)

1. P. D. Kwong, J. R. Mascola, G. J. Nabel, Nat. Rev. Immunol. 13, 693-701 (2013).
2. P. D. Kwong et al., Nature 393, 648-659 (1998).
3. M. G. Joyce et al., J. Virol. 87, 2294-2306 (2013).
4. Y. D. Kwon et al., Proc. Natl. Acad. Sci. U.S.A. 109, 5663-5668 (2012).
5. F. Klein et al., Cell 153, 126-138 (2013).
6. L. Chen et al., Science 326, 1123-1127 (2009).
7. M. Pancera et al., Proc. Natl. Acad. Sci. U.S.A. 107, 1166-1171 (2010).
8. C. C. Huang et al., Science 310, 1025-1028 (2005).
9. J. S. McLellan et al., Nature 480, 336-343 (2011).
10. R. Khayat et al., J. Virol. 87, 9865-9872 (2013).
11. L. Kong et al., Nat. Struct. Mol. Biol. 20, 796-803 (2013).
12. J. P. Julien et al., PLOS Pathog. 9, e1003342 (2013).
13. A. Merk, S. Subramaniam, Curr. Opin. Struct. Biol. 23, 268-276 (2013).
14. J. P. Julien et al., Proc. Natl. Acad. Sci. U.S.A. 110, 4351-4356 (2013).
15. R. Pejchal et al., Science 334, 1097-1103 (2011).
16. A. Harris et al., Proc. Natl. Acad. Sci. U.S.A. 108, 11440-11445 (2011).
17. R. W. Sanders et al., J. Virol. 76, 8875-8889 (2002).
18. J. M. Binley et al., J. Virol. 74, 627-643 (2000).
19. R. W. Sanders et al., PLOS Pathog. 9, e1003618 (2013).
20. R. Ringe et al., Proc. Natl. Acad. Sci. U.S.A. 110, 18256-18261 (2013).
21. R. Henderson et al., J. Mol. Biol. 413, 1028-1046 (2011).
22. S. Wu et al., Structure 20, 582-592 (2012).
23. M. G. Campbell et al., Structure 20, 1823-1828 (2012).
24. X. Li et al., Nat. Methods 10, 584-590 (2013).
25. X. Zhang et al., Proc. Natl. Acad. Sci. U.S.A. 105, 1867-1872 (2008).
26. P. B. Rosenthal, R. Henderson, J. Mol. Biol. 333, 721-745 (2003).
27. S. Chen et al., Ultramicroscopy 135, 24-35 (2013).
28. J. P. Julien et al., Science 342, 1477 (2013).
29. Most of the predicted N-linked glycosylation sites were associated with some additional density in the EM maps (fig. S4). This density is partially discontinuous for the mobile glycan components, providing a spiky appearance surrounding the periphery of the trimer, particularly within gp120 and variable loop regions. Density corresponding to glycans was generally consistent among three independently determined maps, namely BG505 SOSIP.664 bound to three (5.8 Å) or two Fabs (7.9 Å), and BG505 SOSIP.650 bound to three Fabs (8.2 Å). Thus, the spiky appearance of the map is likely due to glycans and not to overrefined or oversharpened data.
30. X. Wu et al., Science 333, 1593-1602 (2011).
31. See supplementary materials on Science Online.
32. W. Wang et al., Retrovirology 10, 14 (2013).
33. Y. Li et al., J. Virol. 82, 638-651 (2008).
34. L. Liu, R. Cimbro, P. Lusso, E. A. Berger, Proc. Natl. Acad. Sci. U.S.A. 108, 20148-20153 (2011).
35. P. Rusert et al., J. Exp. Med. 208, 1419-1433 (2011).
36. W. Weissenhorn, A. Dessen, S. C. Harrison, J. J. Skehel, D. C. Wiley, Nature 387, 426-430 (1997).
37. E. E. Tran et al., PLOS Pathog. 8, e1002797 (2012).
38. J. Liu, A. Bartesaghi, M. J. Borgnia, G. Sapiro, S. Subramaniam, Nature 455, 109-113 (2008).
39. I. A. Wilson, J. J. Skehel, D. C. Wiley, Nature 289, 366-373 (1981).
40. J. S. McLellan et al., Science 340, 1113-1117 (2013).
41. J. E. Lee et al., Nature 454, 177-182 (2008).
42. J. Jardine et al., Science 340, 711-716 (2013).
43. No such differences were observed in control cases between the Fab-labeled protomers within the 2-Fab reconstruction (fig. S16).
44. A. T. McGuire et al., J. Exp. Med. 210, 655-663 (2013).
45. A. Kassa et al., J. Virol. 83, 8364-8378 (2009).
46. M. B. Zwick et al., J. Virol. 77, 5863-5876 (2003).
47. Y. Li et al., J. Virol. 86, 11231-11241 (2012).
48. H.-X. Liao et al., Nature 496, 469-476 (2013).
49. Y. Mao et al., Proc. Natl. Acad. Sci. U.S.A. 110, 12438-12443 (2013).
50. Y. Mao, L. R. Castillo-Menendez, J. G. Sodroski, Proc. Natl. Acad. Sci. U.S.A. 110, E4178-E4182 (2013).
51. R. Henderson, Proc. Natl. Acad. Sci. U.S.A. 110, 18037-18041 (2013).
52. S. Subramaniam, Proc. Natl. Acad. Sci. U.S.A. 110, E4172-E4174 (2013).
53. M. van Heel, Proc. Natl. Acad. Sci. U.S.A. 110, E4175-E4177 (2013).
54. J. Cohen, Science 341, 443-444 (2013).